Inga Zerr and Simon Mead on advances in prion diseases
29:18
Julia Greenland on azathioprine for early Parkinson's disease
14:13
Ian McKeith on dementia with dementia with Lewy bodies
16:01
Ask Nordestgaard on long-term stroke risk in women
10:55
Shiv Saidha on recent updates in the diagnosis of multiple sclerosis
29:05
Michael Rafii on Down syndrome-related Alzheimer’s disease
22:11
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
8:10
Marte-Helene Bjørk on reproductive risks in people with epilepsy
20:10
Geoff Manley on a new classification system for traumatic brain injury
25:04
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
19:22
Marialuisa Gandolfi on the management of chronic pain in Parkinson's disease
12:13
Michael Tymianski on neuroprotection in stroke
24:47
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
18:13
The Lancet Neurology Editors on advances in neurology in 2024
17:30
Florian Krismer and Elizabeth Coon on multiple system atrophy
17:14
Suvankar Pal on the motor neuron disease trial MND-SMART
17:50
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
19:00
Alex Iranzo on sleep and Parkinson's disease
16:44
Adrian Owen on detecting awareness after acute brain injury
17:19
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
15:28
Sanjay Sisodiya on climate change and brain health
20:48
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
23:28
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
25:18
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
12:20
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
21:45